Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts

Published:2011-02-01 Issue:4 Volume:26 Page:608-613
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Marras Connie,McDermott Michael P.,Marek Ken,Rochon Paula,Naglie Gary,Tanner Caroline M.,Rudolph Alice,Shoulson Ira,Lang Anthony E.,

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.23581/fullpdf

Reference18 articles.

1. DATATOP: a multicenter controlled clinical trial in early Parkinson's disease;Parkinson Study Group;Arch Neurol,1989

2. Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease;Parkinson Study Group;Neurology,2007

3. Predicting motor decline and disability in Parkinson's disease: A systematic review;Marras;Arch Neurol,2002

4. [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression;Neurology,2001

5. Parkinson Study Group. Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease;McDermott;Arch Neurol,1995

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time to initiation of symptomatic treatment in untreated Parkinson disease in the Parkinson progression marker initiative cohort: A 10-year follow up;Parkinsonism & Related Disorders;2023-09

2. Antiparkinsonian medication masks motor signal progression in de novo patients;Heliyon;2023-06

3. The Lessebo Effect in Disease Modification Trials in Parkinson's Disease;Movement Disorders;2023-04-24

4. Real-life consequences of cognitive dysfunction in Parkinson's disease;Progress in Brain Research;2022

5. Re‐Analysis of the STEADY‐PD II Trial—Evidence for Slowing the Progression of Parkinson's Disease;Movement Disorders;2021-11-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3